Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $64.2000 (-4.61%) ($62.1000 - $66.8900) on Wed. Apr. 29, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.66% (three month average) | RSI | 33 | Latest Price | $64.2000(-4.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3% a day on average for past five trading days. | Weekly Trend | CAPR declines -2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) XLF(7%) EWI(6%) IVE(6%) IWM(6%) | Factors Impacting CAPR price | CAPR will decline at least -3.83% in a week (0% probabilities). VIXM(-5%) TLT(-5%) SHY(-3%) GLD(-3%) BND(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.83% (StdDev 7.66%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
Resistance Level | $73.93 | 5 Day Moving Average | $70.6(-9.07%) | 10 Day Moving Average | $69.25(-7.29%) | 20 Day Moving Average | $73.93(-13.16%) | To recent high | -37.4% | To recent low | 16.7% | Market Cap | $1.265b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |